Home Join Contact
 

Research Article
Open Access
Identification of a Point Mutation Causing Splitting of Antigenic Domain in M1 Protein of H5n1 Strain from 2006 Outbreak in India
Tamanna Anwar and Asad U Khan*
Interdisciplinary Biotechnology Unit Aligarh Muslim University, Aligarh 202002 India
*Corresponding author: Dr Asad U Khan, Lecturer, Interdisciplinary Biotechnology Unit,
AMU,Aligarh  202002 India,
Tel         : 091-571-2723088,
Fax       : 091-571- 2721776,
E-mail  : huzzi99@hotmail.com
Received August 01, 2008; Accepted September 08, 2008; Published September 13, 2008
Citation: Tamanna A, Asad UK (2008) Identification of a Point Mutation Causing Splitting of Antigenic Domain in M1 Protein of H5N1 Strain from 2006 Outbreak in India. J Proteomics Bioinform 1: 302-306. doi:10.4172/jpb.1000038
 
Copyright: © 2008 Tamanna A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 
Abstract
Influenza virus shows great variation in virulence. Numerous influenza virulence studies have sought to define the roles of each viral gene in disease production.To understand M1 protein it is necessary to study the functional properties of its distinct domains. Until now, in silico studies on M1 protein of Influenza A H5N1 virus are limited. The purpose of this study was to analyze the antigenic domains of the M1 protein of H5N1 strains found epidemic in Navapur (ABG88883) and Jalgaon, India (ABJ96491) during 2006 outbreak, and to identify antigenic differences between M1 proteins of other strains from different origin. It was noticed that the splitting of antigenic domain within position 48 to 69 of M1 was due to point mutation at position 59 from Isoleucine to Methionine. The antigenic regions identified here might be important for the development of diagnostic test for Influenza A H5N1 infection showing discrimination between different antigenic types of M1 protein of Influenza A H5N1.

Keywords
M1 protein; H5N1; Antigenic domain

Introduction
Influenza virus is a typical enveloped (Schulze, 1973 and Laver, 1973] negative-strand RNA virus which is composed of eight single-stranded genomic segments coding for 10 or more polypeptides (Anwar and Khan, 2006; Lamb, 1983; Lamb et al., 1983). The M1 matrix protein of influenza virus is a multifunctional factor involved in several steps of the life cycle of the virus (Helenius, 1992; Martin and Helenius, 1991). It is the most abundant protein found within the virion and has been shown to play a central role in virus assembly (Allen et al., 1980; Lamb 1983;Lamb et al., 1983;Lamb et al., 1981; Lamb et al., 1985). This protein is located at the inner surface of the lipid bilayer of the virion envelope in close proximity to the ribonucleocapsid protein (RNP) complex (Apostolov et al., 1969;Compans et al., 1975; Compans et al., 1979; Schulze 1972). As with all RNA viruses, the influenza virus lacks a proofreader for replication, allowing the virus to mutate quickly. The host immune system selects for mutants by making antibodies to the original strain of virus. This leads to antigenic drift, whereby the virus gradually changes its types or sub-type. Antigenic variation in influenza comes in a multitude of forms, enabling it to effectively evade the immune system. In humans, changes in certain genes can lead to increasing virulence. Interestingly, antigenic drift in avian influenza is at a standstill; mutant viruses contain only silent changes in amino acid sequences [http://www.brown.edu/Courses/Bio_160/ Projects1999/av/]. The most important aspect in the production of antibodies or drug is the design of the peptideantigen. The peptide-antigen is a small segment (15-18 amino acids) of the protein sequence of interest. These peptideantigens can be used for immunization in order to produce antibodies against the protein for which the peptide is formed or the peptides can be used as a basis for small-molecule/ drug targeting. There is a renewed interest to understand the antigenic diversity of influenza virus because of recent outbreaks of influenza epidemics (CDC, 2006). The knowledge thus gained will play a decisive role in influenza vaccine development (Amexis et al., 2001). We have undertaken this study to compare the antigenic proprieties of the Indian isolates of Influenza H5N1 with the homologous region of different subtypes of the Avian flu virus. The predicted antigenic sites of the matrix protein (M1) of H5N1, found in India, have been compared with the antigenic sites of the homologous domains in other subtypes, H5N1.

Materials and Methods

Antigenic Site Analysis
The sequences of Matrix protein (M1) of Influenza A Virus, spread in India during 2005-06 were obtained, which includes sub-types A/chicken/Navapur/Maharashtra/India/ 7972/2006 (H5N1) [GenBank: ABG88883] and A/chicken/ Jalgaon/India/9386/2006 (H5N1) [GenBank: ABJ96491] isolated from chicken were analysed in the present work. Sequences similar to M1 of A/chicken/Navapur/ Maharashtra/India/7972/2006 (H5N1) were extracted from NCBI FTP server ftp://ftp.ncbi.nih.gov/genomes/INFLUENZA/ from the file influenza.faa. Protein sequences of the sub-type H5N1 were sorted out for analysis. The sequences selected for the study are given in table 1. Antigenic sites were predicted using the tool Antigenic at Emboss available at http://bio.dfci.harvard.edu/Tools/EMBOSS/.

Results

Antigenic Site Analysis
Distinct antigenic domains identified in H5N1 strain of Indian origin (ABG88883 & ABJ96491), are reported in Table 1. On comparing the antigenic domains in Indian strain, ABG88883 with the antigenic domains of Turkey, CAJ01905, it was noticed that in Turkey, CAJ01905 there was a single domain at position 48 to 69 while in our India strain, ABG88883, the antigenic domain at this position was splitted into two domains within the same position viz., 48->55 and 60->69. We, then compared Indian strain, ABG88883 with another strain of Indian origin i.e., strains from Jalgaon (ABJ96491). It was found that Jalgaon strain also showed two antigenic domains within the same position, 48->69. To find out the reason for this discrimination of being splitting into two different antigenic domains in some of the strains, 68 different H5N1 strains were analysed for the antigenic domain of M1 protein at 48 -> 69 (Table 2). Through in silico analysis of this antigenic domain revealed that the strains that were having mutation at position 59 (M59I) have two antigenic domains (48->55 and 60->69), within the same region, while strains with single domain (48 -> 69) found to have Isoleucine at position 59. Moreover, it was also noticed that the strains from Germany, Sudan, Russia and Nigeria found to have two antigenic domains within position 48 to 69.

Table 1: Predicted antigenic domains in Influenza A virus of Indian origin during the outbreak of 2006 in Navapur and Jalgaon ( ABG88883 and ABJ96491)

Discussion
To understand the function of M1 protein it is necessary to study the functional properties of its distinct domains (such as antigenic domains). Antigenic sites represent potential candidates for peptide vaccine against the virus; this type of study can help in better understanding of Influenza A H5N1 isolates spread in India. In this work, we identified distinct antigenic regions in the M1 protein of Influenza A H5N1 virus and compared these domains with other H5N1 strains for M1 protein. Sequence based analyses of M1 protein revealed that although there exists very high sequence similarity at protein level, various strains have acquired certain mutations which confer strain-specific properties.

Table 2: Comparison of antigenic domains at position 48 to 69 within 68 different strains of Influenza virus A H5N1 for M1 protein from different geographic regions.

It is known that a phenotypic property such as antigenicity is the result of 'spatio-temporal' hierarchical processes. Exact mapping of the same at molecular level is difficult due to the fact that there exists complexity in terms of intermolecular interactions which may be discrete or continuous (Flower et al., 2003). Thus, a bioinformatics approach was utilized for this analysis. It was found out that the reason for splitting of the antigenic domain is the point mutation at position 59 (M59I). Our data shows that the strains which have Isoleucine at position 59 show single antigenic domain while the strains with methionine at this position are having two antigenic domains within the region 48 to 69 (Table 2). It was also noticed that the two strains isolated from Indian subcontinent are showing similarity for the presence of antigenic domain (48 -> 69).

Conclusion
Antigenic sites represent potential candidates for the peptide vaccine against H5N1. In silico approach has the potential to become an important tool to understand disease pathogenesis and designing antigen- specific therapies. The peptides, derived from antigenic sites may serve as ideal antigens to develop site-specific immunoassays for serological diagnosis.

Acknowledgements
Department of Biotechnology, Ministry of Science and Technology, Government of India is acknowledged for the financial support. This work was supported by DBT grant BT/PR7507/BID/07/201/2006 to AUK.

References

  1. Allen H, McCauley, Waterfield JM, Gething MJ (1980) Influenza virus RNA segment 7 has the coding for two polypeptides. Virology 107: 548-551.  » PubMed   »  Google Scholar

  2. Anwar T and Khan AU (2006) Matrix protein 1: A comparative in silico study on different strains of influenza A H5N1 Virus. Bioinformation 1: 253-56.  » PubMed   »  Google Scholar

  3. Amexis G, Oeth P, Abel K, Ivshina A, Pelloquin F, et al. (2001) Quantitative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 98: 12097-102. » CrossRef   » PubMed   »  Google Scholar

  4. Apostolov K and Flewett TH (1969) Further observations on the structure of influenza virus A and C. J Gen Virol 4: 365-370. » CrossRef   » PubMed   »  Google Scholar

  5. Centers for Disease Control and Prevention 2006 (http:/ /www.cdc.gov/).

  6. Compans RW, Klenk HD (1979) Viral membranes, In H. Fraenkel-Conrat and R. R. Wagner (ed.) Comprehensive virology vol 13 Phenum Publishing Corp New York p 293-407.

  7. Compans RW and Choppin PW (1975) Reproduction of myxoviruses. Compr Virol 4: 179-252.

  8. Helenius A (1992) Unpacking the incoming influenza virus. Cell 69: 577–578. » CrossRef   » PubMed   »  Google Scholar

  9. Schulze IT (1973) Adv Virus Res 18: 1–56.

  10. Lamb RA (1983) The influenza virus RNA segments and their encoded proteins, In P. Palese and D. W. Kingsbury (ed.), Genetics of influenza virus. Springer-Verlag KG, Vienna p 21-69.

  11. Lamb RA, Choppin PW (1983) The structure and replication of influenza virus. Annu Rev Biochem 52: 467- 506. » CrossRef   » PubMed   »  Google Scholar

  12. Lamb RA, Lai CJ, Choppin PW (1981) Sequences of mRNAs derived from genome RNA segment 7 influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci USA 78: 4170-4174. » CrossRef   » PubMed   »  Google Scholar

  13. Lamb RA, Zebedee SL (1985) Influenza M2 protein is an integral membrane protein expressed on the infected cell surface. Cell 40: 627-633. » CrossRef   » PubMed   »  Google Scholar

  14. Laver WG (1973) Adv Virus Res 18: 57–104.

  15. Martin K and Helenius A (1991) Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell 67: 117– 130. » CrossRef   » PubMed   »  Google Scholar

  16. Schulze IT (1972) The structure of influenza virus. II. A model based on the morphology and composition of subviral particles. Virology 47: 181-196. » CrossRef   » PubMed   »  Google Scholar
This Article
DOWNLOAD
» XML (38 KB)
» PDF (111 KB)
» Citation
CONTRIBUTE

SHARE

EXPLORE
Related Article at